CompoAtlas

I-Sight

I-Sight, licence 80066568: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Xymogen
NPN or DIN-HM
80066568
Status
Active licence
Licence date
25 January 2016
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Acide 2-aminoéthanesulfonique

Source : Taurine

200.0 mgNot calculated
Tagetes erecta

Source : Tagetes erecta - Fleur

75.0 mgNot calculated
Tagetes erecta

Source : Tagetes erecta - Fleur

Potency : 20.0 % Lutein

Not specifiedNot calculated
Zinc

Source : Diglycinate de zinc

17.5 mg17,500 µg
Acide L-alpha-acétamido-bêta-mercaptopropionique

Source : N-Acétyl-L-cystéine

100.0 mgNot calculated
Vaccinium myrtillus

Source : Vaccinium myrtillus - Fruit

90.0 mgNot calculated
Vaccinium myrtillus

Source : Vaccinium myrtillus - Fruit

Potency : 25.0 % Anthocyanidins

Not specifiedNot calculated
Acide DL-alpha-lipoïque

Source : Acide DL-alpha-lipoÏque

75.0 mgNot calculated
3,3',4',5,7-Pentahydroxyflavone

Source : Quercétine dihydraté

50.0 mgNot calculated
Lycopène tout trans

Source : Lycopène

3.0 mgNot calculated

Non-medicinal ingredients

Hypromellose, Cellulose microcristalline, NA, Dioxyde de silicium, Stéarate de magnésium, Acide stéarique

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)1.0 Capsule1.0 Tous les jours

Uses authorised in Canada

A factor in the maintenance of good health. Helps in connective tissue formation. Helps to maintain healthy skin. Helps the body to metabolize carbohydrates, fats and proteins. Helps to maintain immune function. Provides antioxidants for the maintenance of good health. Antioxidant for the maintenance of good health. Antioxidant for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. An antioxidant.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80066568

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line